loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Alogliptin Benzoate

    Menu

    Alogliptin Benzoate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,067Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203414 / DOSAGE - TABLET;ORAL - EQ 12.5MG BASE;500MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALOGLIPTIN BENZOATE(UNII: EEN99869SC)
    (Alogliptin - UNII:JHC049LO86)     		Alogliptin12.5mg | 12.5mg
    Metformin hydrochloride(UNII: 786Z46389E)
    (Metformin - UNII:9100L32L2N)     		Metformin hydrochloride1000mg | 500mg

    Inactive Ingredients

    Ingredient Name
    Padagis Israel Pharmaceuticals Ltd
    CROSPOVIDONE (120 .MU.M)(68401960MK)
    ferric oxide yellow(EX438O2MRT)
    HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6)
    magnesium stearate(70097M6I30)
    mannitol(3OWL53L36A)
    microcrystalline cellulose(OP1R32D61U)
    POVIDONE, UNSPECIFIED(FZ989GH94E)
    talc(7SEV7J4R1U)
    titanium dioxide(15FIX9V2JP)